Use of the Atalante exoskeleton
Sponsors
Wandercraft, Centre Hospitalier Universitaire de Nīmes
Conditions
Cerebrovascular AccidentCerebrovascular DisordersChronic StrokeHemiparesisHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)Hemiparesis;Poststroke/CVALower ExtremityParalysis, Lower Limbs
Unknown Phase
Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis
CompletedNCT04110561
Start: 2018-05-05End: 2018-11-16Updated: 2019-10-07
Evaluation of the Use of the Atalante System in Patients Presenting a Non-traumatic Hemiplegia in Acute-subacute Phase (15 Days to 6 Months).
CompletedNCT04187209
Start: 2019-09-11End: 2021-01-13Updated: 2024-09-26
Evaluation of the Use of the Atalante Exoskeleton in Patients Presenting an Hemiplegia Due to Cerebrovascular Accident
CompletedNCT04694001
Start: 2021-04-12End: 2022-03-28Updated: 2022-04-27
Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)
RecruitingNCT06107010
Start: 2023-06-12End: 2026-02-28Target: 66Updated: 2025-02-04
Effect of the Atalante Exoskeleton on Standing and Walking in Individuals With Paraplegia: A Prospective Controlled-Environment Study in a Rehabilitation Context
CompletedNCT06941896
Start: 2017-01-31End: 2019-09-30Updated: 2025-04-24